BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24042290)

  • 1. [Choice of drug in hypertension].
    Schultz M; Aksnes TA; Høieggen A; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1802-3. PubMed ID: 24042290
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension.
    Ritter JM
    BMJ; 2011 Apr; 342():d1673. PubMed ID: 21474511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
    Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
    Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern approaches to the treatment of primary arterial hypertension].
    Bokarev IN; Matvienko EV
    Klin Med (Mosk); 2013; 91(3):4-8. PubMed ID: 23789444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in diabetes.
    Hunter JD; Ravert PK; Lassetter JH; Williams M
    Adv NPs PAs; 2011 Jan; 2(1):25-9; quiz 30. PubMed ID: 21329229
    [No Abstract]   [Full Text] [Related]  

  • 8. [B. Gjelsvik replies].
    Gjelsvik B
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2226-7. PubMed ID: 24226314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood pressure treatment--source of debate].
    Gjelsvik B
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1792. PubMed ID: 24042272
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood Pressure Treatment--towards consensus on many things].
    Kjeldsen SE; Schultz M; Vinkenes K; Aksnes TA; Høieggen A
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2226. PubMed ID: 24226313
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical inquiries. Which combination drug therapies are most effective for hypertension?
    Crawford P; Dy D; Carney M
    J Fam Pract; 2011 Nov; 60(11):684-6. PubMed ID: 22049354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].
    Jungmann E
    Dtsch Med Wochenschr; 1991 May; 116(22):859-62. PubMed ID: 2036945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk.
    Sciarretta S; Palano F; Tocci G; Baldini R; Volpe M
    Arch Intern Med; 2011 Mar; 171(5):384-94. PubMed ID: 21059964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparative characteristics of the renal protective properties of angiotensin-converting enzyme inhibitors and calcium channel blockers].
    Kolesnyk MO; Lapchyns'ka II; Hromova AIe; Kassyr KhI
    Lik Sprava; 2000; (3-4):11-5. PubMed ID: 10921249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
    Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASCOT - more than a horse race!
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2005; 14(5):262-3. PubMed ID: 16257870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.